Results 81 to 90 of about 1,800 (193)
Fumarylacetoacetate hydrolase (FAH) catalyzes the final step in Tyr degradation pathway essential to animals but not well understood in plants. Previously, we found that mutation of SSCD1 encoding Arabidopsis FAH causes cell death under short day, which ...
Zhou Zhou +7 more
doaj +1 more source
Glycerophospholipid metabolism, arginine‐proline metabolism, TCA cycle and alanine‐aspartate‐glutamate metabolism were significantly dysregulated after ATEC exposure. Downregulated l‐glutamate and l‐glutamine which participate in TCA cycle, resulting in the collapse of energy production and cytotoxicity.
Bing Jie Ma +8 more
wiley +1 more source
Comparative analysis of gene and disease selection in genomic newborn screening studies
Abstract Genomic newborn screening (gNBS) is on the horizon given the decreasing costs of sequencing and the advanced understanding of the impact of genetic variants on health and diseases. Key to ongoing gNBS pilot studies is the selection of target diseases and associated genes to be included.
Isabel R. Betzler +8 more
wiley +1 more source
Background: Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive inborn error of metabolism caused by deficiency of fumarylacetoacetate hydrolase enzyme.
Seyed Mohsen Dehghani +4 more
doaj
Background: A high level of succinylacetone (SA) in blood is a sensitive, specific marker for the screening and diagnosis of hepatorenal tyrosinemia (HT1, MIM 276700).
Hao Yang +9 more
doaj +1 more source
Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family [PDF]
Carrier of tyrosinemia type I was diagnosed by sequencing FAH (fumarylacetoacetate hydrolase) gene. It leads to the identification of heterozygous status for both c.648C>G (p.Ile216Met) and c.1159G>A (p.Gly387Arg) mutations in exons 8 and 13 ...
Ankleshwaria, Chitra M. +3 more
core +2 more sources
Successive Drug Therapy for a Very Rare Autosomal Diseases [PDF]
It is very rare to find reports concerning a drug therapy successively treating chromosomal abnormalities. In this paper, we are reporting a successive use of nitisinone in treating a fatal and very rare autosomal disease called hereditary tyrosinemia ...
Al-Noaemi, Mohammed Chyad +1 more
core +2 more sources
TOP2 poisons such as etoposide are widely employed anti‐cancer drugs, but their use is associated with DNA damage that can lead to therapy‐related acute leukaemia. Etoposide is activated by the myeloid‐specific enzyme myeloperoxidase (MPO) to more DNA damaging forms, and we show that MPO inhibition reduces etoposide‐induced DNA damage in bone marrow ...
Ian G. Cowell, Caroline A. Austin
wiley +1 more source
Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
Anibh Martin Das Department of Pediatrics, Hannover Medical School, Hannover, Germany Abstract: Medical therapy for hereditary hepatorenal tyrosinemia (hereditary tyrosinemia type 1, HT-1) with nitisinone was discovered incidentally, and is a by-product ...
Das AM
doaj
Abstract Blood microsampling (BµS) offers an alternative to conventional methods that use plasma or serum for profiling human health, being minimally invasive and cost effective, especially beneficial for vulnerable populations. We present a non‐systematic review that offers a synopsis of the analytical methods, applications and perspectives related to
Pauline Couacault +7 more
wiley +1 more source

